Patent linkage refers to the system or process by which a country links drug marketing approval to the status of the patent(s) corresponding to the originator’s product. This article provides a snapshot of the patent linkage position in the US vis-à-vis Asia and the Pacific. United States. The Food and Drug Administration (FDA) maintains a […]
Malaysia - Status Of Divisional Applications Clarified
For many years, the courts have raised objections to the non-unity of the patent applications and divisional applications. This matter and the provisions of Section 26B of the Patents Act 1983 in Malaysia were addressed in the above case. The case of B Braun Melsungen AG & Anor v. Terumo Kabushiki Kaisha & Anor centered […]
New Patents Order In Brunei Darussalam
A new Patents Order, 2011 has come into force in Brunei Darussalam, effective January 1, 2012. This legislation repeals the previous patent legislation, i.e. The Inventions Act, Chapter 72. Previously, Brunei, a member state of ASEAN, did not have a national patent system. Patent protection was obtained by re-registration of a granted UK, European Patent […]
Thailand - Can You Register A Functional Design?
Registration of designs in Thailand is governed by the Department of Intellectual Property and the Thai Patent Act. There are lacunas in the Act design patents, especially where it proves difficult to draw the line between invention patents and design patents. Section 3 of the Act merely provides that a design is ‘...any configuration of […]
ASEAN and India - The Importance of Industrial Design Protection
Of the four pillars of intellectual property protection – patents, industrial designs, trademarks and copyrights – perhaps the most overlooked is that for industrial (ornamental) designs. In most countries, the available design protection is generally very narrow, with a minimal halo of protection around the exact design depicted in the application. Why would an applicant […]
Malayisa - How to Use Utility Innovations
Malaysia’s Patents Act 1983 provides different rules & requirements in respect of the conferment of protection upon minor inventions: utility innovations. An advantage of utility innovations in contrast with regular patents is that they have a lower threshold for patentability. Section 17 of the Act defines a utility innovation as: “any innovation which creates a […]
Thailand - Mediation Achieves Impressive Success Rate
Litigation in Thailand has often been stigmatised as lengthy, expensive, cumbersome and convoluted. Indeed, the weight of this fear burdens not so much the infringers of IP rights but, disproportionately more in fact, brand owners themselves. Where litigation in Thailand has revealed many shortcomings, it has been cast away as commercially non-sensical for the protection […]
Efficient, Cost-Effective Patent Procurement In Southeast Asia
Global patent filing trends, especially in Southeast Asia, have been steadily on the rise, and anyone who has been involved with the preparation, filing, prosecution and maintenance of patents around the world will readily agree that global patenting is a highly complicated and expensive undertaking requiring careful planning and serious considerations. Patenting a single invention […]
Malaysia - Implementation Of Data Exclusivity(DE)
The National Pharmaceutical Control Bureau (NPCB) in Malaysia ensures the quality, efficacy and safety of pharmaceuticals through the evaluation of technical data and laboratory test conducted during clinical trial. Upon fulfilment of all safety regulations, approval is given for marketing. Malaysia is a member of World Trade Organization (WTO). Under Article 39.3 of the TRIPs […]
Malaysia - Generic Pharma Seemingly Manage to ‘Invent Around’ Innovator Patent
Sanofi-Aventis took on Dabur Pharma in the latest pharmaceutical patent case law to be decided at the Malaysian High Court (D-22IP-46-2009). Sanofi is the owner of a process patent - MY ’481 - for the production of Docetaxel trihydrate, which they market as Taxotere. Worldwide annual sales of Taxotere totaled approximately US$3.1 billion dollars in […]